The premier mobile IV therapy company drew over 200 attendees to its November wellness and education event featuring elite wellness experts, IVDRIPS activations, and glam experiences.
Medit, a global leader in 3D intraoral scanning solutions, and OraQ, a pioneer in AI-powered clinical intelligence, today announced a strategic partnership designed to accelerate the integration of artificial intelligence and real-time clinical insight into digital dentistry.
Rockwell Medical, Inc. a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that Heather Hunter was promoted to Chief Operating Officer, and will continue to report to the Company's President and CEO, Dr. Mark Strobeck.
Kardium, a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced the successful completion of the first commercial procedures using its integrated mapping and ablation system, the Globe Pulsed Field System, following recent approval from the U.S. Food and Drug Administration (FDA).
RefleXion Medical, an external‑beam theranostic oncology company, announced first results from the PREMIER Registry (NCT05406167) evaluating its SCINTIX® biology-guided radiotherapy, or BgRT, platform in patients with lung and bone tumors. The findings, presented at the 2025 ASTRO Annual Meeting, showed local control of 100 percent at nine months post-treatment with no reported Grade 2 or higher adverse events. The data represent the first prospective, multi-institutional evidence of SCINTIX therapy’s clinical impact.
Phraxis, Inc., a leader in vascular access innovation, announced the successful completion of the first commercial case using the EndoForce™ Anastomotic Connector, marking a historic milestone in the treatment of dialysis patients worldwide.
Imperative Care, Inc announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Symphony® Thrombectomy System to treat pulmonary embolism (PE), a life-threatening condition caused by blood clots blocking an artery in the lungs.
Brightonix Imaging, a global leader in cutting-edge medical imaging technology, is proud to announce that its flagship product, the PHAROS PET Scanner, has received FDA clearance for commercial distribution in the United States. This milestone marks a new era of precision and efficiency in nuclear imaging and positions Brightonix Imaging at the forefront of medical innovation.
Lunit a leading provider of AI for cancer diagnostics and therapeutics, announced a significant expansion of its footprint in Italy's public healthcare system. As of June 2025, more than 10 Local Health Authorities—commonly known as ASL (Azienda Sanitaria Locale)—are using Lunit's AI solutions to enhance cancer screening and optimize imaging workflow. These ASLs collectively serve a population of over 8.5 million, accounting for approximately 14% of Italy's total population.
Avails Medical, Inc., a leader in the development of rapid, automated, and fully electrical antibiotic susceptibility testing (AST) technologies, announced that it has signed its first U.S. commercial customer, a world renowned academic medical center and flagship hospital for a six-hospital system, for the company's groundbreaking eQUANT™ System.